Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 400.00
0.00 (0.00%)
Sep 10, 2026, 5:24 PM IDT
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 119.71 million as of September 11, 2026. Its market cap has decreased by -49.90% in one year.
Market Cap
119.71M
Enterprise Value
111.63M
Revenue
2.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
400.00
ChartMarket Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 119.71M, a decrease of -90.07%. That is a compound annual growth rate of -38.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 119.71M | -34.30% |
| Dec 31, 2025 | 182.22M | -32.71% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
| Dec 15, 2021 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 128.91B |
| Danel (Adir Yeoshua) | 2.54B |
| Amal Holdings A.D. | 2.09B |
| BrainsWay | 1.71B |
| Bonus BioGroup | 202.09M |
| InterCure | 191.19M |
| Golden House | 167.11M |
| Rekah Pharmaceutical Industry | 129.90M |